Frontiers of vascular biology: Mechanisms of inflammation and immunoregulation during arterial remodelling

• References

• 1 Weber C, Zernecke A, Libby P. The multi-facetted contributions of leukocyte subsets to atherosclerosis. Nat Rev Immunol 2008; 08: 802-815.
• 2 Chavakis E, Choi EY, Chavakis T. Novel aspects in the regulation of the leukocyte adhesion cascade. Thromb Haemost 2009; 102: 191-197.
• 3 Soehnlein O, Zernecke A, Weber C. Neutrophils launch monocyte extravasation by release of granule proteins. Thromb Haemost 2009; 102: 198-205.
• 4 Lievens D, Wouter J, Eijgelaar WJ. et al. The multifunctionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost 2009; 102: 206-214.
• 5 Schuett H, Luchtefeld M, Grothusen C. et al. How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb Haemost 2009; 102: 215-222.
• 6 van Puijvelde GHM, van Wanrooij EJA, Hauer AD. et al. Effect of natural killer T cell activation on initiation of atherosclerosis. Thromb Haemost 2009; 102: 223-230.
• 7 Eijgelaar WJ, Heeneman S, Daemen MJAP. The vulnerable patient: 1 Refocusing on the plaque?. Thromb Haemost 2009; 102: 231-239.
• 8 Steffens S, Montecucco F, Mach F. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury. Thromb Haemost 2009; 102: 240-247.
• 9 Jennings L. Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 2009; 102: 248-257.
• 10 Koenen RR, von Hundelshausen P, Nesmelova IV. et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 2009; 15: 97-103.